Search Results

Immune cells called Gamma Delta T cells can act independently to identify and kill cancer cells, defying the conventional view of the immune system.

Researchers have unpicked the complexity of an unusual group of rare tumours, a subset of which might be candidates for treatment with a type of cancer immunotherapy.

A ‘rule book’ to guide precision combination immunotherapies and speed up the development of new lung cancer treatments will be created as part of a new collaboration between the Crick, Cancer Research UK and Bristol Myers-Squibb.

Crick group leaders Guillaume Salbreux and Axel Behrens, along with Chris Dunsby from Imperial College London, have been awarded a £2m grant from the Engineering and Physical Sciences Research Council (EPSRC).